In all cases where a post-implantation angiogram revealed anything more than a trivial residual leak an attempt to re-cross the duct was made to enable further positioning of coils. Importantly, despite re-crossing a PDA with implanted coils, no coils embolised during this manoeuvre. However, a 5 mm coil embolised from a 2-5 mm duct in an 18 month old patient in whom an initial 8 mm x 4 loop coil was removed because it protruded into the pulmonary artery. The embolised coil was retrieved and subsequently an 8 mm x 3 loop coil followed by a 5 mm x 5 loop coil were implanted.
GROUP A Ten patients required a single coil whereas the remainder required multiple coils to produce a satisfactory angiographic result. Two coils were deployed (fig 2) in 20 patients (44%), 11 (24%) required three coils, and three (7%) required four coils. One two year old child weighing 10-8 kg needed seven coils to achieve an on the table occlusion. In two cases the first coil was left attached to the delivery wire while the PDA was re-crossed with a guidewire. In five cases it was not possible to re-cross the PDA from the venous side and therefore a 4 F multipurpose catheter (Microvena) was used to re-cross the PDA, from the arterial side, to implant a second or subsequent coil. In six cases the duct required an arterial approach for coil implantation. An arteriovenous guidewire loop was set up to enable transvenous deployment in one patient.
Complete occlusion was achieved in 40/45 (89%) at 24 hours, 41/45 (91 %) at one month, and 44/45 (98%) by six months post procedure as assessed by colour flow Doppler echocardiography. One patient had a trivial residual leak on colour flow Doppler echocardiography six months after implantation.
GROUP B
In one patient it was not possible to cross the duct and the procedure was abandoned. An arterial approach was employed in eight patients. Seventeen (68%) of 25 patients required a single coil to obtain closure at catheterisation. Two coils were implanted in a further seven patients (fig 3) . A 30 month old child with an adjustable button device and a 17 mm Rashkind device already in situ required five coils to obtain angiographic occlusion because of multiple jets around the previous devices.
Twenty two (88%) were completely occluded at 24 hours. All but one patient, with Figure 3 Lateral aortograms (A) before and (B) after implantation of two 5 mm spring coils used to treat a residual leak after implantation ofa 
COMPLICATIONS
There were no clinical complications and only one coil embolisation. Seventeen coils were electively withdrawn, because of excessive protrusion into either the aorta or pulmonary artery, without difficulty before release. Inability to detach the coil from the delivery wire occurred on three occasions. Difficulty with coil release was encountered in seven cases, necessitating additional anti-clockwise rotations of the delivery wire. This may have been due to over-engaging the helical screw mechanism. We recommend no more than three clockwise turns to engage the coil on the delivery system. COST 
ISSUES
We calculate that in our unit the cost differential between this and other devices for PDA occlusion relates almost exclusively to materials because the procedure times were similar. The Rashkind device costs £2300, whereas three coils plus a delivery system costs about £300.
The widely used Rashkind double umbrella device requires two operators and a large delivery catheter of 8 or 11 F diameter. In contrast the detachable coil delivery system is smaller and can be easily assembled by a single operator. Residual shunting after closure with a Rashkind device is common. AIn one case in our series a previously sealed duct recanalised after implantation of a 17 mm device: a similar case was reported by others.8 The early occlusion rate with the detachable coil system seems to be better than that of the Rashkind double umbrella device. Our series includes 35 native PDAs with minimum diameters of 3 mm or less. These would be expected to achieve a good long-term occlusion rate with the 12 mm diameter Rashkind double umbrella. Subsequent endothelialisation of the umbrella device will produce complete occlusion in about 90%; however, this may take up to three years. Khan et Tynan .'4 The use of this new detachable (Cook) spring coil would provide significant savings on equipment costs compared with the Rashkind umbrella. In our unit, using two or three coils per patient, the cost saving is about £2000 per procedure. This we believe would reverse the cost analysis performed by Gray et al in favour of transcatheter occlusion. 3 The detachable (Cook) spring coil technique offers a safe, controlled, and cost effective method of transvenous occlusion for paediatric patients with either a native or residual PDA. Despite multiple operators we have achieved a high occlusion rate (98% for native and 96% for residual PDAs at six months follow up). Significant cost saving with increased efficacy is possible with this multiple coil occlusion technique. Although larger studies are required to explore its role more fully, we consider that transcatheter occlusion by multiple detachable spring coils is the treatment of choice in most patients with a PDA.
